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The resistance to dieldrin (RDL) receptor is an insect
γ-aminobutyric acid (GABA) receptor, characterized by the
dieldrin resistance mutation that was pivotal to understanding
target based insecticide resistance. RDL is the target for various
non-competitive antagonists, including dieldrin and fipronil,
as well as novel acting compounds such as the meta-diamides
and isoxazolines. Therefore the RDL receptor has returned to
center stage as a relevant and effective insecticide target. Our
understanding of the function of RDL in vivo is still unfolding,
with the discovery of species specific post-transcriptional
modifications such as alternative splicing and RNA editing,
modifications shown to influence the pharmacology of the
receptor. Exposing these receptors to insecticides also evokes
ever evolving mechanisms of mutagenesis, and a number of
contributory mutations have been identified both in field and
laboratory resistant insects, occurring in parallel to the dieldrin
resistance mutation. We present an overview of these variations
and discuss the impact on the pharmacology of GABA and
various insecticides.
Introduction
The targeting of insect neuronal receptors is one of the main mechanisms
of insecticidal action. However, our understanding of these neuronal receptors
and their functions in vivo are still unfolding, with the continuing discovery
and functional analysis of post-transcriptional modifications such as alternative
splicing and RNA editing. By the same token, exposing these receptors to
insecticides evokes ever evolving mechanisms of mutagenesis by nature,
contributing to insecticide resistance or offsetting the fitness costs of other
mutations. An overview of these variations and their effects on receptor
pharmacology are provided on the resistance to dieldrin (RDL) receptor, the most
studied of the insect γ-aminobutyric acid (GABA) receptors and the target for
both historic and novel non-competitive antagonists (NCAs) (1).
The RDL receptor is involved in rapid inhibitory synaptic transmission,
utilizing GABA as its neurotransmitter. As the first invertebrate GABA receptor
to be identified, most sequence and functional analysis has been conducted in the
fruit fly model Drosophila melanogaster, in which the subunit was first identified
and functionally expressed (2, 3). The RDL receptor plays a key role in various
processes, most notably the regulation of sleep (4), aggression (5) and olfaction
(6, 7), and in D. melanogaster, RDL is expressed both in the embryonic and adult
central nervous system (8, 9).
As amember of the cys-loop ligand-gated ion channel (cysLGIC) superfamily,
the RDL receptor consists of a pentameric subunit structure, centered around
a central pore. In turn, the RDL subunit is composed of extracellular N- and
C-termini, four transmembrane domains (M1 – M4), the second of which lines the
ion channel; and a large intracellular loop between M3 and M4 (10). The agonist
binding site is located in the N-terminal extracellular domain and consists of
distinct regions (loops A-F) (11). Also in the N-terminal domain is the dicysteine
loop, which is characteristic of the cysLGIC superfamily. In addition to RDL, the
cysLGIC superfamily contains other receptor targets for insecticides, including
the glutamate gated chloride channels and nicotinic acetylcholine receptors (1,
12, 13).
GABA binds at the subunit interface, altering the conformation of the receptor
and allowing the passage of chloride ions, which initiate the cascade of inhibitory
action. By this function, the insect RDL receptor is most related to vertebrate
GABAA receptors, though pharmacologically it does have some differences (14,
15).
The RDL receptor was identified and characterized following the discovery
of a mutation located in the ion channel pore forming M2 (amino acid position
301) of D. melanogaster Rdl. This mutation rendered the RDL receptor resistant
to the antagonistic effects of 10 μM dieldrin, which is a cyclodiene insecticide (3).
The Rdl subunit has since been cloned from several insect orders, including those
of agricultural pests (e.g. red flour beetle Tribolium castaneum and planthopper
Laodelphax striatellus (16, 17)), pests afflicting domesticated animals (cat flea,
Ctenocephalides felis (18)), human and animal disease vectors (house fly Musca
domestica, and mosquitoes Anopheles gambiae and Aedes aegypti (19–21)) and
beneficial species (miridbugCyrtorhinus lividipennis and honeybee Apis mellifera
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(22, 23)). In most cases, an insect has only one Rdl gene, however, there are
exceptions, such as the presence of two Rdl genes in the pea aphid (Acyrthosiphon
pisum) (24) and the diamondback moth (Plutella xylostella) (25), while the silk
worm (Bombyx mori) possesses three Rdl genes (26). The coding sequence of Rdl
is remarkably conserved between diverse insect species, usually showing 70-90%
identity at the amino acid level (27, 28). The M2 mutation in the RDL subunit
(commonly referred to as the A2′ mutation, which signifies an alteration in the
second amino acid position of the ion channel domain) (15) has been extensively
studied since its discovery, and is utilized as a diagnosticmarker for resistance (29).
However, several other RDL subunit mutations have recently been discovered in
field and laboratory selected resistant insects, and interestingly always in parallel
with the A2′ mutation (30–32).
The RDL receptor is a target for a number of neuromodulatory and
insecticidal compounds including lindane (33), picrotoxin (34), cyclodienes (e.g.
dieldrin, endosulfan) (2), phenylpyrazoles (e.g. fipronil) (35) and macrocyclic
lactones (e.g. ivermectin) (36). Recently, the RDL receptor has returned to center
stage as a novel target for the isoxazolines (37, 38), meta-diamides (39) and
meroterpenoid chrodrimanins (40), that target different binding sites and have
the distinct advantage of acting on RDL bearing subunits containing the M2
resistance mutation (15, 40).
The study of RDL receptor is facilitated by the ability to express high levels of
the homomeric receptor in Xenopus laevis oocytes and other expression systems
(41–44), but the exact composition of the subunits in vivo remains unknown.
These homomeric receptors maintain most of the pharmacological properties
of native insect GABA receptors but their response to some benzodiazepines is
different (14, 15), suggesting that other subunits may co-assemble with RDL in
vivo. This is supported by in vitro studies showing that RDL can co-express with
the GABA receptor subunits GRD (GABA/glycine-like receptor of Drosophila)
(45) and LCCH3 (ligand-gated chloride channel homologue 3) (46) as well as
the glutamate gated chloride channels (GluCls) (21, 47). However, there is other
evidence to suggest that these subunits may not necessarily co-assemble in vivo
(48, 49).
The RDL receptor is likely to be far more complex than is suggested by the
common perception that it is a homomeric. This is because alternative splicing and
RNA editing have been found to increase the diversity of the Rdl transcriptome
(15, 50). In addition, evidence has come to light that these variations can affect
the pharmacology of the receptor and influence the actions of insecticides (51, 52).
In the following chapter we will consider the recent molecular variations
identified in the insect RDL receptor and discuss the impact of these variations on
the receptor pharmacology of GABA and various insecticides.
Environmentally-Induced Variations: The Effects of RDL
Resistance Mutations on Receptor Pharmacology
It is 24 years since the original dieldrin resistance mutation at position 301
(A2′S/G) was identified in an RDL subunit (3), and it is one of the most significant
examples of direct target site resistance to date. Dieldrin was removed from
the market several decades ago, but may persist in the environment (53). This
combined with the potential for cross-resistance with currently used insecticides
such as endosulfan and fipronil (32, 54), may suggest why the dieldrin resistance
mutation still persists in insect populations (55, 56). With novel insecticides
emerging that target the RDL receptor, albeit with different mechanisms of
action (57), it seems timely to review the presence of novel insecticide associated
mutations that have been discovered in recent years (summarized in Table 1).
The amino acid alanine in the channel forming M2 domain, corresponding
to position 301 (A2′) in the D. melanogaster RDL subunit, is mutated most often
to serine (18, 58, 59) or glycine (58, 60) to confer resistance to channel blocking
insecticides such as dieldrin and at varying levels to fipronil (15, 58, 61). It was
recently found that the glycine mutation in fact facilitated a greater resistance to
fipronil than the serine mutation (both in vivo and in vitro) inD. melanogaster (62).
More recently, in 2010 and 2011, another mutation at the same site was observed
in two fipronil resistant field populations of planthopper, in which alanine at the
same position was mutated to asparagine (A2′N) (44, 63).
The first mutation reported to co-exist with the A2′ mutation was T350M
(Table 1), isolated from a laboratory selected Drosophila simulans population
resistant to dieldrin, also showing a high level of resistance to fipronil (31). This
mutation, located in the M3 domain, was always found in the presence of A2′G.
Functional experiments with electrophysiology applied to expressed RDL subunit
isoforms in X. laevis oocytes revealed that the T350M mutation contributed to
fipronil resistance, as the IC50 of the A2′G/T350M isoform for fipronil (221 nM)
was significantly increased from that of A2′G alone (93 nM) and wild-type (31
nM) (31). Furthermore, expression of an RDL subunit isoform containing only
T350M also showed reduced sensitivity to fipronil (IC50 215 nM), suggesting that
the mutation may also individually contribute to resistance.
The Drosophila T350 double resistance profile was also found to be
conserved in RDL subunits of the malaria mosquito An. gambiae, that were
highly resistant to dieldrin (20). Here, the M3 mutation T345M in the An.
gambiae RDL subunit (Table 1), which is equivalent to T350M in D. simulans,
was also found in the presence of the A2′G mutation (20). As the mosquitoes in
this study were collected from wild populations showing phenotypic resistance to
dieldrin, the mutations observed here may represent resistance mutations present
in the field. In contrast with the double mutant RDL isoform from D. simulans
however, the T345M mutation in An. gambiae did not appear to contribute to
fipronil resistance, as a double mutation or individually (20). This supports
observations in transgenic D. melanogaster, whereby fipronil resistance was not
heightened by the presence of the T-M mutation, both alone and in combination
with A2′G (62). It is speculated that the T-M mutation in An. gambiae may
therefore play a structural rather than functional role, potentially offsetting the
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fitness costs imposed by A2′G (20, 62). Modeling of the receptor indicates that
the two mutations are indeed in close proximity and hence capable of functional
interaction (62). The EC50 of A2′G (60 μM) for GABA was also found to
be significantly lower than that of the A2′G/T345M double mutant (198 μM),
indicating that the T-M mutation may serve to offset the heightened sensitivity to
GABA, that would otherwise be detrimental to neuronal signaling (20).
A D. melanogaster Rdl subunit mutation, M360I, in the intracellular loop
between M3 and M4, was observed alongside the A2′S mutation (Table 1) in a
gene duplication that contained one wild type copy and one double mutant (A2′S/
M360I) copy of Rdl (64). This duplication was associated with intermediate levels
of dieldrin resistance and heat shock recovery, suggesting that the duplication may
offset the temperature sensitive fitness cost associated with the A2′Smutation (64).
Interestingly, M360 can be recoded to valine through RNA A-to-I editing (51).
It was found that in the duplicated Drosophila Rdl, there were greater levels of
RNA editing at I360 than at the wild-type M360 copy (64), which may suggest
a link between RNA editing and the A2′S resistance mutation. However, the
individual contribution of M360I to insecticide resistance has yet to be determined
at a molecular/functional level.
In Anopheles funestus Rdl, a V327I substitution was found to be associated
with the A2′S mutation in field collected samples of dieldrin resistant mosquitoes
in Cameroon and Burkina Faso (Table 1) (56). The valine to isoleucine substitution
is present in the loop between the M2 andM3 domains. Interestingly, the mutation
was always found in conjunction with the A2′S mutation, but at a lower frequency
than was observed for A2′S (56). The link between this mutated isoform and the
resistance phenotype, as well as the functional consequences of this mutation, have
however not as yet been investigated.
A number of different contributory mutations to the less common A2′N
mutation have also been identified Rdl subunits from various species of
planthopper (Table 1) (65–67). An R340Q mutation was found in the presence of
A2′N in an RDL subunit of fipronil resistant Sogatella furcifera collected from a
rice paddy in Japan (65). The mutation is present in the intracellular loop between
the M3 and M4 domains, in relative close proximity to the T345M/T350M
mutations found in An. gambiae and D. simulans (20, 31). As with the V327I
mutation in An. funestus RDL, the R340Q mutation was present at a lower
frequency than A2′N, being present in only 9 of 17 cDNA clones carrying the
A2′N mutation (65). Using a membrane potential assay and Drosophila Mel-2
cells stably expressing the homomeric RDL mutant isoforms, it was shown
that the R340Q did not contribute significantly to fipronil resistance, both in
combination with A2′N and alone. This result, combined with the location in
the intracellular loop suggest, as with the T345M/T350M mutation, that this
substitution may have a more subtle structural role and/or play a role in offsetting
the fitness costs of the A2′N mutation.
In the brown planthopper Nilaparvata lugens, another recent study revealed
a mutation in combination with A2′S, a Q359E mutation between M3 and M4
of the RDL subunit (Table 1) (30). The mutations were observed when field
collected insects were driven to resistance using the fiprole insecticide ethiprole.
Ethiprole has particular relevance to N. lugens, as along with fipronil it has
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replaced imidacloprid as a method of insect control in Asia, following resistance
to neonicotinoids (68). There were differential effects of the A2′S mutation on
the sensitivity of ethiprole and fipronil, a somewhat unexpected finding as the
structures differ only by an ethylsulfinyl substituent in ethiprole, compared to
a trifluoromethylsulfinyl moiety in fipronil (for structures see reference (69)).
Both in vitro (homomeric RDL expressed in X. laevis oocytes) and in vivo (D.
melanogaster insecticide bioassays) methods demonstrated that the A2′S mutation
contributes to ethiprole resistance (30). This effect was most pronounced in vivo,
whereby D. melanogaster with the A2′S mutation exhibited 4000-fold resistance
in comparison to the wild-type strain. The Q359E mutation, however, did not
contribute significantly to resistance in vitro, indicating that the A2′S mutation
is the main mechanism of target site resistance. The authors speculate that the
presence of the Q359E mutation may be owing to a structural linkage between
the two mutations, or that the Q359E mutation confers a fitness advantage. It
is difficult to envisage how Q359E may offset any fitness associated with A2′S
considering that the mutation, both singly and as a double mutant, did not impact
on the potency of GABA (30).
Secondary mutations were also found in the M2 domain of the RDL subunit
from the planthopper L. striatellus (66). Sequencing of the Rdl gene from field
collected insects driven to 87-fold resistance to fipronil revealed the A2′Nmutation
in combination with either an R305Q or R305W mutation (Table 1). The strain
exhibited low cross-resistance to dieldrin and endosulfan and resistance was not
affected by detoxification enzymes, suggesting that target site mutations are likely
to be responsible for fipronil resistance (66).
In N. lugens, an R299Q mutation, also in the M2 domain of the RDL
subunit, was recently identified in addition to the A2′S mutation (Table 1) (67).
The A2′S/R299Q double mutant was found in insect populations from China,
Thailand and Vietnam, with R299Q occurring at a lower frequency than A2′S.
In addition, the R299Q mutation was identified during laboratory selection with
fipronil (up to a resistance ratio of 237-fold) after the A2′S mutation had reached
100% penetrance. This suggests that R299Q is a secondary mutation potentially
associated with persistent fipronil exposure. The mutations, as in previous
studies, were only found in parallel, which the authors speculate may be because
of the fitness costs associated with the R299Q mutation alone. Indeed, expression
of the R299Q mutant subunit expressed as a homomeric receptor individually
reduced the GABA potency almost 11 times (EC50 = 413 μM) to that of wild type
receptors (38 μM), suggesting a high fitness cost. This is a much larger reduction
in potency than was observed with the A2′S mutation (EC50 = 19 μM, 2 times
lower). In contrast, the double mutant receptor restored the GABA potency to
comparable levels with the wild-type (EC50 = 54 μM), perhaps offsetting the
fitness costs associated with increased sensitivity to GABA. In addition, the A2′S
mutation conferred low levels of resistance to fipronil (IC50 45 nM compared to
20 nM in wild-type). However, in combination with R299Q, the sensitivity to
fipronil was significantly decreased (IC50 96 nM), suggesting the double mutant
also contributes to fipronil resistance. Therefore the A2′S and R299Q subunit
mutations are likely to have both a compensatory and synergistic relationship; to
offset fitness costs and increase fipronil resistance, respectively.
6
Table 1. Resistance Mutations Found in Association with the A2′ Mutation in the RDL Subunit of Various Insect Species. The
Mutations Are Listed in Order of Position within the Protein Sequence, with the Insect Species Detected, Resistance Ratio if
Calculated and Geographical Location from Which They Were Isolated, unless They Were Obtained via Laboratory Selection.
RDL mutation
associated with A2′
Insect species Resistance ratio Geographical location isolated
M2 domain
A2′S and R299Q N. lugens Fipronil: 237
China, Vietnam, Thailand, plus via
laboratory selection (67)
A2′S and R305Q
or R305W
L. striatellus Fipronil: 87
Laboratory selection (field collected strain
from Japan) (66)
Loop between M2-M3 domains
A2′S and V327I An. funestus Not determined Africa (Burkina Faso and Cameroon) (56)
M3 domain
A2′G and T345M An. gambiae Not determined
Laboratory selection (field collected strain
from Democratic Republic of Congo) (20)
A2′G and T350M D. simulans (Eyguières 42) Fipronil: 20,000 Laboratory selection (31)
Intracellular loop between M3-M4 domains
A2′N and R340Q S. furcifera Not determined Japan (65)
Continued on next page.
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Table 1. (Continued). Resistance Mutations Found in Association with the A2′ Mutation in the RDL Subunit of Various Insect
Species. The Mutations Are Listed in Order of Position within the Protein Sequence, with the Insect Species Detected, Resistance
Ratio if Calculated and Geographical Location from Which They Were Isolated, unless They Were Obtained via Laboratory
Selection.
RDL mutation
associated with A2′
Insect species Resistance ratio Geographical location isolated
A2′S and Q359E N. lugens
Under ethiprole selection:
Ethiprole: >14,000
Fipronil: >860
Laboratory selection (field collected strain
(Nl55) from India) (30)
A2′S and M360I D. melanogaster Dieldrin: >4000 USA (64)
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Naturally-Occurring Variations: Alternative Splicing and RNA
Editing
Alternative splicing and RNA editing are post-transcriptional modifications
that enhance the diversity of the transcriptome, thereby increasing the number
of products from a single gene (70, 71). Ion channel proteins functioning in
the nervous system undergo a notably high level of RNA editing, commonly in
functionally significant regions, which may serve as a mechanism for facilitating
rapid neuronal signaling (72). The importance of alternative splicing and RNA
editing is highlighted by their dysregulation, which results in neurodegenerative
phenotypes (73–75). These mechanisms may also be particularly influential in
insect genomes, serving to expand the repertoire of what would otherwise be a
small complement of proteins. For example, insects possess less than 30 cysLGIC
subunit genes, as opposed to 102 in Caenorhabditis elegans and 45 in humans
(27, 76, 77).
The Effects of Alternative Splicing on RDL Receptor Pharmacology
Alternative splicing is the process in pre-messenger RNA (mRNA), whereby
introns are spliced out and various exons are introduced, removed or substituted
to form the final processed mRNA. In this way, a single gene codes for multiple
proteins, as a result of the alternatively spliced exons forming multiple protein
products (78, 79).
D. melanogaster Rdl is composed of nine exons, two of which, exons 3
(variants a and b) and 6 (variants c and d) (Figure 1) are alternatively spliced
to produce subunit isoforms ac, ad, bc and bd, all of which are transcribed in
vivo (50, 51). Real time PCR and analyses of clones amplified from adult D.
melanogaster and An. gambiae cDNA reveal that the Rdlbd variant is the most
prevalent splice form in vivo (51, 80). However the preference for the splice
variant transcript appears to be different at the embryonic stage, with Rdlbc being
the most abundant (50), indicating varying requirement for the different isoforms
at different stages of development.
Alternative splicing of exons 3 and 6 is conserved in diverse insect species
including the African malaria mosquito An. gambiae (80), the small brown
planthopper L. striatellus (81), the silkworm B. mori (26), the honeybee A.
mellifera (28), beetles T. castaneum andOulema oryzae (82, 83) and the parasitoid
wasp Nasonia vitripennis (27) also revealed these common splice regions. In
contrast, the white-backed planthopper S. furcifera has an additional splice variant
at exon 3 (65). The diamondback moth, P. xylostella, has two Rdl-encoding
genes, both of which are alternatively spliced at only exon 3 (25). This suggests
that even within insect orders, the level of alternative splicing can differ, creating
species specific RDL subunit isoforms.
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Figure 1. Schematic illustration showing how post-transcriptional modifications
can diversify the insect RDL subunit, in this case that of D. melanogaster.
Alternative splicing yields two variants each for exons 3 (variants a and b) and 6
(variants c and d) changing amino acid residues in the N-terminal extracellular
domain where agonist binding occurs. Residues that are different in alternative
exons are shown in bold. Differential splicing generates M3-M4 intracellular
loops of different lengths as shown by sequences with the accession numbers
NP_729462.2 and NP_523991.2 (sequences directly submitted to the NCBI
database). RNA editing leads to the R122G substitution in the N-terminal
extracellular domain, I283V in M1, whereas N294D and M360V occur in
intracellular domains.
Exons 3 and 6 are located in the N-terminal extracellular domain, within
proximity of agonist binding. In particular, exon 6 contains loops C and F, which
contribute to the ligand-binding site (15). It was therefore not surprising to find
that the splice isoforms in Drosophila differed in their sensitivity to GABA and
various GABA analogues when expressed using the X. laevis expression system
and two-electrode voltage clamp electrophysiology (51, 84–86). The sensitivity to
GABA was in the order bc>ac>ad>bd, ranging in EC50 from 20 ± 0.2 µM (RDLbc)
to 152 ± 10 µM (RDLbd) (51).
More recently it has been shown that different subunit isoforms of RDL
can also arise from variation in the large intracellular loop between M3 and
M4. Here, instead of using alternative exons, the use of different splice acceptor
sites generates intracellular loops of varying lengths (Figure 1). For example,
the miridbug C. lividipennis contains two RDL subunit isoforms differing by
a 31 amino acid insertion in the intracellular loop (23, 28). Two-electrode
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voltage-clamp electrophysiology applied to C. lividipennis Rdl expressed in X.
laevis oocytes showed that these two isoforms significantly differed in their
sensitivity to fipronil, with the presence of the insertion significantly increasing
the IC50 from 6.47 ± 1.12 µM to 16.83 ± 2.30 µM. This suggests that diversity
in this large intracellular loop may enhance the tolerance to fipronil or other
insecticides. Another insect species, A. mellifera, has three differentially spliced
M3-M4 isoforms of RDL (22, 28). These variants, unlike those in C. lividipennis,
did not differ in their sensitivity to fipronil (22). Interestingly, the site of insertion
disrupts a putative protein kinase C phosphorylation consensus site, conserved in
both A. mellifera, C. lividipennis andD. melanogasterRDL (22). Phosphorylation
of the intracellular loop can influence events such as protein assembly, receptor
desensitization and insecticide sensitivity (87–90). Therefore differential splicing
has the potential to affect insecticide actions in a species specific manner.
The differential effects of species specific subunit isoforms on insecticide
sensitivity described above are highly pertinent, since species such as C.
lividipennis and A. mellifera are both beneficial insects. This is highly relevant
considering that the use of fipronil has been restricted by the European Union
(91) for its suspected negative effects on bees.
These findings hint at the complex level of species specific differential
splicing that can occur in insects, which may impact on the response of receptors
to insecticides. It remains to be seen whether differential splicing of the
intracellular loop of RDL subunits are highly conserved in diverse insects,
including pest species, and whether this presents another route to reducing
sensitivity to insecticides.
The Effects of RNA Editing on RDL Receptor Pharmacology
RNA editing also diversifies the number of products produced from a single
gene, but via single nucleotide substitutions, initiated by adenosine deaminases
acting on RNA (ADAR) enzymes (92, 93). In the most prevalent form of RNA
editing, known as A-to-I editing, ADAR enzymes deaminate adenosine to inosine,
which is then translated as guanosine (94). The result is a sequence transcript
dissimilar to that of the genomic DNA, potentially changing amino acid residues
that may affect protein structure and function.
For example, four RNA editing sites that alter amino acid residues were
identified in clones amplified from D. melanogaster Rdl cDNA (51, 72) (Figure
1). In an analysis of >100 clones, the edit sites R122G, I283V, N294D andM360V
were found in 16 different combinations, predominantly in the bd splice variant
background (51). These amino acid substitutions are in structurally significant
regions, making it likely that they will affect receptor function. For instance,
R122G is located between ligand binding loops D and A, suggesting that it may
influence agonist binding. Es-Salah et al. confirmed this finding by showing
that when the arginine is replaced with glycine the GABA EC50 is significantly
increased (52). Functional expression of the different editing isoforms also
generated a range of sensitivities to GABA in D. melanogaster RDL (EC50s of
3-193 μM), showing that singly and in combination, the edit sites directly affect
agonist potency (51).
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Interestingly, the choice of splice variant arising from the alternative use of
exons 3 and 6 influenced the potency of GABA in addition to RNA editing. This
was shown by significantly different GABAEC50s for the ad and bd splice variants
with the same edit combination, suggesting that editing and splicing may act in
concert to further broaden the functional diversity of the RDL receptor (51).
Resistance mutations in RDL subunits were also investigated in combination
with RNA editing. The N-terminal R122G edit was investigated in comparison
with an A2′G/T350M mutated RDL receptor isoform (52). The sensitivity to
both GABA and fipronil was significantly reduced by the R122G addition,
suggesting that RNA editing is able to affect insecticide sensitivity in RDL
receptor isoforms bearing resistance mutations. The authors speculate that as
fipronil acts preferentially on agonist-bound receptors and R122G reduces the
potency of GABA, the reduction in the proportion of agonist bound receptors
may affect fipronil binding (52). Lees et al. also investigated the effect of
the RNA edit site I283V on fipronil sensitivity in A2′S mutant homomeric D.
melanogaster RDL and found that this edit site did not affect GABA binding or
fipronil sensitivity (36). This difference in effect may be due to the position of
I283V in the M1 domain of the subunit, as it is not in close proximity to locations
of agonist or antagonist binding.
RNA editing can generate isoforms that are highly species specific. For
example, one of the two Rdl genes (RDL 1) from B. mori generates transcripts
with two potential RNA editing sites that alter two amino acid residues at the
C-terminal end, a region completely different to those altered in D. melanogaster
RDL (26). Recently, RNA editing sites were also found in the RDL subunit
of various mosquito species, which are not completely conserved with D.
melanogaster (80). In this study, a comprehensive sequence analysis was
conducted on the RDL subunit from the mosquito disease vectors; An. gambiae,
Culex pipiens and Ae. aegypti. Nine putative RNA editing sites were observed
in Rdl cDNA sequences; five in Ae. aegypti, seven in Cx. pipiens and eight
sites in An. gambiae. Two of these, I278V and N289D, were conserved in
D. melanogaster (51). Therefore the remaining sites were not only mosquito
specific, but also in some cases mosquito species specific. The functional effects
of different RNA editing isoforms in RDL subunits from An. gambiae were
investigated in the bd splice variant background (80). As with D. melanogaster,
the edit combination generated a spectrum of potencies to GABA, with EC50s
ranging from 5 ± 1 to 246 ± 41 μM in the 18 isoforms tested. Interestingly,
the EC50 increased in line with an increase in the number of RNA edited sites.
RNA editing did not however have an effect on the sensitivity of fipronil. This is
perhaps unsurprising as none of the editing sites are in the pore-lining M2 region
important for fipronil binding (15).
The macrocyclic lactone ivermectin also acts on the GABA receptor, but
the exact mechanisms of action are not clear. Ivermectin has been found to
potentiate the GABA response of vertebrate GABA receptors (95) and the D.
melanogaster RDL receptor (96) using patch clamp electrophysiology applied to
cell lines and the FLIPR membrane potential assay. ForM. domestica homomeric
RDL receptors expressed in X. laevis oocytes, ivermectin was also found to
potentiate currents induced by low concentrations of GABA (EC5) (97). However,
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ivermectin has been shown to act as an antagonist on An. gambiae (80), D.
melanogaster (36) and M. domestica (97) RDL currents, as homomeric receptors
expressed in Xenopus oocytes, when induced by a GABA concentration higher
than the EC50.
RNA editing of An. gambiae RDL isoforms influences the potency of
ivermectin, where it was shown to significantly reduce the IC50 of the unedited
receptor from 457 ± 118 nM to 50 ± 24 nM in the completely edited isoform (80).
Ivermectin was also found to directly activate the An. gambiae RDL receptor
as well as potentiate the GABA-induced responses at concentrations below the
EC50 (80). Differences between the edited and unedited isoforms were also
observed under these experimental conditions. Concentrations of 0.01 μM and
0.03 μM ivermectin potentiated currents induced by GABA at the EC20 in the
unedited receptor isoform, but not in the edited isoform (80). The triple actions
(agonistic, potentiating and antagonistic) of ivermectin were also observed for the
M. domestica RDL receptor (97) where the authors speculated that the number
of orthosteric binding sites in the pentamer occupied by GABA, may determine
whether ivermectin is a potentiator or antagonist. It remains to be seen whether
RNA editing sites in An. gambiae RDL subunits contribute individually or in
conjunction to elicit changes in the sensitivity to ivermectin. Of particular interest
would be the N183G edit site of the RDL subunit from An. gambiae, which is
within the cys-loop, and therefore could influence communication between the
GABA binding regions and the transmembrane domain (98). This information
may have relevance to controlling vector-borne diseases as ivermectin has been
shown to reduce the longevity of An. gambiae mosquitoes (99).
Intriguingly, not all insect species contain an RDL receptor that is RNA edited.
For instance, RNA A-to-I editing sites have not been detected in RDL from the
honey bee (A. mellifera), the red flour beetle (T. castaneum) and the parasitoid
wasp (N. vitripennis) (27, 28, 82). RNA editing, therefore, can recode the highly
conserved genomic sequence for Rdl in a species-specific manner. Why RDL
subunits of some insect species undergo RNA editing and others do not remains a
mystery. The finding that RNA editing generates numerous receptor isoforms of
RDL in An. gambiae suggests that the mosquito GABA receptor requires a higher
level of plasticity than that of the honey bee.
Conclusions and Future Prospects
Identification of the dieldrin resistance mutation in the RDL receptor was
pivotal to understanding themechanism of target site resistance in insects. Dieldrin
is no longer in use, however fipronil, which also shows varying levels of cross-
resistance to the RDL receptor, is used worldwide in various applications ranging
from the control of agricultural pests to the treatment of various parasitic diseases
(100). Therefore understanding variations in the structure and function of the RDL
receptor is relevant to understanding mechanisms of resistance in the field, as well
as a target for emerging novel classes of insecticides (39, 40).
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Future investigations of the RDL receptor will likely continue to reveal
further resistance associated mutations. The A2′S/G/N are the common variants
of the classically conserved RDLmutation in M2, although a number of additional
mutations have recently been identified in highly insecticide resistant insects
(Table 1). In all instances, the second mutations were associated in parallel
with the A2′ mutation. Identification of these mutations may indicate a gradual
adaptive response to changing levels of insecticides in the environment. However,
it may also be possible that these mutations have been present in populations for
some time, but were not previously identified as the entire coding region of the
Rdl gene is commonly not sequenced. To presume that the A2′ mutation is central
to RDL receptor-based insecticide resistance may encourage diagnostic checks
for resistance to concentrate solely on the M2 domain. This has the danger to
miss other mutations that may be important (32).
There is increasing evidence that post-transcriptional modifications can
impact on RDL receptor pharmacology, providing another reason to sequence the
whole coding region to identify subunit isoforms that may arise from alternative
splicing and RNA editing. There is no doubt that in the future novel splicing
and editing isoforms of the RDL receptor will continue to be identified as more
cDNA clones are investigated. It would be additionally advantageous to further
investigate the effects of splicing and editing in pest species in order to investigate
their contribution as potential factors in altering the tolerance to insecticides.
Future experiments with potentially new insecticides that act on the RDL receptor
could include elucidating whether splicing and RNA editing affect the potency of
these novel compounds. Can the findings of species-specific splicing and RNA
editing of RDL subunits be exploited? Perhaps future insecticide discovery efforts
may identify compounds preferentially acting on RDL receptor isoforms found
only in pest species. This is considerably timely since the use of fipronil and
neonicotinoids have been restricted amidst fears that they are having a detrimental
effect on non-target organisms (100).
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